TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›WAY›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Waystar Holding Corp. (WAY) financials

Income statement

Waystar Holding Corp. (WAY) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$705M$791M$944M$1.10B
Revenue growth—12.2%19.3%16.5%
Operating income$89.5M$142M$124M$249M
Operating margin12.7%18.0%13.1%22.7%
Net income-$51.5M-$51.3M-$19.1M$112M
Net margin-7.3%-6.5%-2.0%10.2%
EPS (diluted)-$0.42-$0.42-$0.13$0.61

Cash flow

Waystar Holding Corp. (WAY) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow$103M$51.5M$170M$310M
Capital expenditures$17.4M$21.5M$27.3M$26.5M
Free cash flow$85.2M$29.9M$143M$283M
Share buybacks$2.45M$688K$844K$0.00

Balance sheet

Waystar Holding Corp. (WAY) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$64.6M$35.6M$182M$61.4M
Total assets—$4.58B$4.58B$5.79B
Total liabilities—$2.53B$1.50B$1.91B
Long-term debt—$2.20B$1.22B$1.46B
Shareholders' equity$2.11B$2.05B$3.08B$3.88B
Retained earnings—-$202M-$221M-$109M
Shares (wtd avg diluted)122M122M150M185M

Every figure is extracted from Waystar Holding Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Waystar Holding Corp.'s annual revenue?
Waystar Holding Corp. (WAY) reported $1.10B of revenue for fiscal year 2025 — up 16.5% from $944M in FY2024, per its annual report filed with the SEC.
Is Waystar Holding Corp. profitable?
Yes — WAY earned $112M of net income in FY2025, a 10.2% net margin, per SEC filings.
What is Waystar Holding Corp.'s free cash flow?
$283M in FY2025 (operating cash flow $310M minus $26.5M of capital expenditures), from the SEC cash-flow statement.
Does WAY pay a dividend?
Waystar Holding Corp. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full WAY analysis — verdict, score & filings →Is WAY a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.